Imatinib‐induced agranulocytosis in patients with gastrointestinal stromal tumors

E-ISSN： 1552-4604|55|8|920-925

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.8, 2015-08, pp. : 920-925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2325-2333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical Management in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience

Oncology, Vol. 90, Iss. 5, 2016-04 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Gastrointestinal Stromal Tumors: Biology and Treatment

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 187-197

Karger

Access to resources Recommend Favorite

PET-Negative Gastrointestinal Stromal Tumors

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-10 ,pp. : 508-513

Karger

Access to resources Recommend Favorite

A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 326-332

Karger

Access to resources Recommend Favorite